Rachel Groth

Rachel Groth, Ph.D., is currently Vice President and Head of Neuroscience Research at BridgeBio in Palo Alto, CA. She has more than 10 years’ experience leading drug discovery and early development efforts in industry across diverse therapeutic areas (e.g., neuroscience, immunology, renal, and oncology) and drug modalities (e.g., small molecules, monoclonal antibodies, and antisense oligonucleotides). Before joining BridgeBio, Rachel held roles of increasing responsibility at Pfizer and Biogen. Rachel earned her B.A. in Biology and Neuroscience from Macalester College, her Ph.D. in Neuroscience from the University of Minnesota, and completed her postdoctoral training in Molecular and Cellular Physiology at Stanford University.